Hims & Hers vs Marek Diagnostics
Vial Take
Both platforms share a clean federal compliance record and overlap on TRT across 40 states, so either is a reasonable starting point for hormone therapy depending on what you want to see under the hood. Hims & Hers scores 13 points higher and carries LegitScript certification, a rare credential that adds an independent layer of verification, but you'll find the physician side completely opaque there, while Marek at least surfaces physician-supervised review even though its pharmacy chain and LegitScript status are unverified. If your priority is credential transparency on the clinical side, Marek gives you more of that; if you want a certified pharmacy operation and a stronger compliance paper trail, Hims & Hers is the cleaner call.
Biggest Differences
- Pharmacy disclosureHims & Hers publishes its compounding partner (Hims & Hers), so you can verify the supply chain; Marek Diagnostics does not name a pharmacy partner publicly.
- LegitScript certificationHims & Hers holds LegitScript certification (the credential required to advertise on Google and Meta); Marek Diagnostics does not.
- Trust Score gap (13 points)Hims & Hers scores 88/100 to Marek Diagnostics's 75/100, a 13-point spread driven by the differences below.
Hims & Hers
Telehealth PlatformMarek Diagnostics
Lab / DiagnosticHims & Hers
Want to run a full compliance report on either provider?
Related
Other comparisons featuring these providers
Comparison based on public federal and state records including NPI Registry, FDA enforcement database, and PCAB accreditation directory. Updated weekly. Not a medical endorsement.